| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.993 | 0 | 0.996 | Protein kinase C gamma inhibitor | 0.996 0 DBMET01440 0.989 0 DBMET01441 | DBMET01440 | |
| 0.992 | 0.001 | 0.995 | Protein kinase A inhibitor | 0.995 0.001 DBMET01440 0.972 0.002 DBMET01441 | DBMET01440 | |
| 0.983 | 0.001 | 0.984 | Protein kinase C epsilon inhibitor | 0.984 0.001 DBMET01440 0.957 0.001 DBMET01441 | DBMET01440 | |
| 0.975 | 0.001 | 0.982 | Protein kinase C nu inhibitor | 0.982 0.001 DBMET01440 0.925 0.001 DBMET01441 | DBMET01440 | |
| 0.971 | 0.001 | 0.971 | Protein kinase C alpha inhibitor | 0.971 0.001 DBMET01440 0.97 0.001 DBMET01441 | ||
| 0.97 | 0 | 0.986 | Protein kinase C beta inhibitor | 0.986 0 DBMET01440 0.973 0 DBMET01441 | DBMET01440 | |
| 0.961 | 0.001 | 0.966 | Protein kinase C eta inhibitor | 0.966 0.001 DBMET01440 0.908 0.001 DBMET01441 | DBMET01440 | |
| 0.953 | 0 | 0.967 | Protein kinase C mu inhibitor | 0.967 0 DBMET01440 0.862 0.001 DBMET01441 | DBMET01440 | |
| 0.937 | 0.002 | 0.96 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.96 0.001 DBMET01440 0.92 0.002 DBMET01441 | DBMET01440 | |
| 0.924 | 0.001 | 0.977 | Protein kinase C zeta inhibitor | 0.977 0.001 DBMET01440 0.833 0.002 DBMET01441 | DBMET01440 | |
| 0.922 | 0.001 | 0.938 | Protein kinase C delta inhibitor | 0.938 0.001 DBMET01440 0.854 0.002 DBMET01441 | DBMET01440 | |
| 0.92 | 0.001 | 0.92 | MAP kinase kinase 6 inhibitor | 0.895 0.002 DBMET01440 0.893 0.002 DBMET01441 | ||
| 0.886 | 0.003 | 0.94 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.94 0.003 DBMET01440 0.832 0.003 DBMET01441 | DBMET01440 | |
| 0.864 | 0.003 | 0.864 | EphB2 antagonist | 0.773 0.003 DBMET01440 0.759 0.004 DBMET01441 | ||
| 0.862 | 0.003 | 0.948 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.948 0.002 DBMET01440 0.821 0.003 DBMET01441 | DBMET01440 | |
| 0.86 | 0.001 | 0.86 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.703 0.003 DBMET01440 0.786 0.001 DBMET01441 | ||
| 0.856 | 0.001 | 0.856 | MAP3K9 inhibitor | 0.548 0.001 DBMET01440 0.829 0.001 DBMET01441 | ||
| 0.817 | 0.003 | 0.951 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.951 0.002 DBMET01440 0.784 0.003 DBMET01441 | DBMET01440 | |
| 0.814 | 0.002 | 0.814 | Hematopoietic | 0.788 0.002 DBMET01440 0.776 0.002 DBMET01441 | ||
| 0.802 | 0.001 | 0.802 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.758 0.001 DBMET01440 0.765 0.001 DBMET01441 | ||
| 0.796 | 0.002 | 0.796 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.69 0.003 DBMET01440 0.722 0.003 DBMET01441 | ||
| 0.737 | 0.002 | 0.791 | MAP-kinase-activated kinase 5 inhibitor | 0.791 0.002 DBMET01440 0.708 0.002 DBMET01441 | DBMET01440 | |
| 0.698 | 0.006 | 0.698 | Vasodilator, peripheral | 0.649 0.01 DBMET01440 0.659 0.009 DBMET01441 | ||
| 0.687 | 0.003 | 0.687 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.543 0.003 DBMET01440 0.564 0.003 DBMET01441 | ||
| 0.675 | 0.004 | 0.675 | Non-steroidal antiinflammatory agent | 0.362 0.018 DBMET01440 0.556 0.005 DBMET01441 | ||
| 0.668 | 0.001 | 0.668 | MAP kinase kinase 3 inhibitor | 0.608 0.001 DBMET01440 0.594 0.001 DBMET01441 | ||
| 0.645 | 0.001 | 0.645 | Death-associated protein kinase 2 inhibitor | 0.618 0.002 DBMET01440 0.611 0.002 DBMET01441 | ||
| 0.633 | 0.001 | 0.669 | Protein kinase C iota inhibitor | 0.669 0.001 DBMET01440 0.526 0.001 DBMET01441 | DBMET01440 | |
| 0.615 | 0.004 | 0.807 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.807 0.003 DBMET01440 0.568 0.004 DBMET01441 | DBMET01440 | |
| 0.612 | 0.002 | 0.612 | Cyclin-dependent kinase 3 inhibitor | 0.559 0.002 DBMET01440 0.545 0.002 DBMET01441 | ||
| 0.606 | 0.002 | 0.606 | MAP kinase kinase 4 inhibitor | 0.463 0.002 DBMET01440 0.518 0.002 DBMET01441 | ||
| 0.583 | 0.004 | 0.583 | Death-associated protein kinase 3 inhibitor | 0.452 0.01 DBMET01440 0.533 0.005 DBMET01441 | ||
| 0.558 | 0.001 | 0.558 | MAP kinase kinase 5 inhibitor | 0.504 0.001 DBMET01440 0.49 0.002 DBMET01441 | ||
| 0.54 | 0.002 | 0.54 | Death-associated protein kinase 1 inhibitor | 0.469 0.002 DBMET01440 0.448 0.002 DBMET01441 | ||
| 0.55 | 0.021 | 0.55 | Immunosuppressant | 0.519 0.028 DBMET01440 0.534 0.024 DBMET01441 | ||
| 0.524 | 0.004 | 0.524 | Protein kinase (CK1) gamma 3 inhibitor | 0.379 0.008 DBMET01440 0.432 0.005 DBMET01441 | ||
| 0.536 | 0.018 | 0.536 | Immunomodulator | 0.492 0.024 DBMET01440 0.46 0.029 DBMET01441 | ||
| 0.516 | 0.005 | 0.516 | Tyrosine-protein kinase receptor antagonist | 0.182 0.048 DBMET01440 0.386 0.01 DBMET01441 | ||
| 0.498 | 0.004 | 0.498 | Ribosomal protein S6 kinase inhibitor | 0.403 0.005 DBMET01440 0.461 0.004 DBMET01441 | ||
| 0.49 | 0.006 | 0.49 | TRKC antagonist | 0.303 0.026 DBMET01440 0.4 0.011 DBMET01441 | ||
| 0.483 | 0.005 | 0.483 | Protein kinase (CK1) gamma 1 inhibitor | 0.324 0.016 DBMET01440 0.382 0.01 DBMET01441 | ||
| 0.475 | 0.002 | 0.528 | Phosphodiesterase 6D inhibitor | 0.269 0.003 DBMET01440 0.528 0.001 DBMET01441 | DBMET01441 | |
| 0.474 | 0.002 | 0.499 | Protein kinase C theta inhibitor | 0.499 0.002 DBMET01440 0.394 0.003 DBMET01441 | DBMET01440 | |
| 0.474 | 0.005 | 0.587 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.587 0.004 DBMET01440 0.404 0.005 DBMET01441 | DBMET01440 | |
| 0.453 | 0.004 | 0.457 | Neurotrophic factor | 0.362 0.005 DBMET01440 0.457 0.004 DBMET01441 | DBMET01441 | |
| 0.453 | 0.005 | 0.453 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.338 0.012 DBMET01440 0.349 0.011 DBMET01441 | ||
| 0.442 | 0.005 | 0.442 | TRKA antagonist | 0.169 0.04 DBMET01440 0.349 0.008 DBMET01441 | ||
| 0.441 | 0.008 | 0.441 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.278 0.039 DBMET01440 0.354 0.018 DBMET01441 | ||
| 0.436 | 0.005 | 0.444 | Topoisomerase I inhibitor | 0.408 0.005 DBMET01440 0.444 0.005 DBMET01441 | DBMET01441 | |
| 0.405 | 0.004 | 0.486 | Check point kinase 1 inhibitor | 0.486 0.004 DBMET01440 0.334 0.005 DBMET01441 | DBMET01440 | |
| 0.399 | 0.004 | 0.399 | Activin receptor-like kinase 4 inhibitor | 0.281 0.006 DBMET01440 0.277 0.006 DBMET01441 | ||
| 0.403 | 0.011 | 0.403 | MAP kinase kinase 2 inhibitor | 0.177 0.098 DBMET01440 0.343 0.022 DBMET01441 | ||
| 0.405 | 0.021 | 0.598 | Anticonvulsant | 0.598 0.007 DBMET01440 0.453 0.016 DBMET01441 | DBMET01440 | |
| 0.384 | 0.008 | 0.384 | Protein kinase (CK1) gamma inhibitor | 0.207 0.042 DBMET01440 0.292 0.019 DBMET01441 | ||
| 0.382 | 0.013 | 0.382 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.271 0.036 DBMET01440 0.298 0.028 DBMET01441 | ||
| 0.369 | 0.013 | 0.516 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.293 0.02 DBMET01440 0.516 0.005 DBMET01441 | DBMET01441 | |
| 0.356 | 0.004 | 0.452 | MAP kinase 13 inhibitor | 0.452 0.004 DBMET01440 0.316 0.005 DBMET01441 | DBMET01440 | |
| 0.349 | 0.005 | 0.43 | MAP kinase 12 inhibitor | 0.43 0.004 DBMET01440 0.31 0.006 DBMET01441 | DBMET01440 | |
| 0.348 | 0.012 | 0.348 | Protein-tyrosine kinase Lyn inhibitor | 0.226 0.037 DBMET01440 0.25 0.029 DBMET01441 | ||
| 0.4 | 0.064 | 0.444 | Transcription factor NF kappa B inhibitor | 0.198 0.171 DBMET01440 0.444 0.054 DBMET01441 | DBMET01441 | |
| 0.341 | 0.006 | 0.341 | Protein kinase (CK1) gamma 2 inhibitor | 0.21 0.029 DBMET01440 0.279 0.014 DBMET01441 | ||
| 0.335 | 0.003 | 0.335 | Phosphodiesterase VI inhibitor | 0.146 0.007 DBMET01440 0.313 0.003 DBMET01441 | ||
| 0.331 | 0.009 | 0.516 | Cyclin-dependent kinase 1 inhibitor | 0.516 0.005 DBMET01440 0.271 0.014 DBMET01441 | DBMET01440 | |
| 0.317 | 0.01 | 0.317 | I kappa B kinase epsilon inhibitor | 0.19 0.08 DBMET01440 0.261 0.032 DBMET01441 | ||
| 0.31 | 0.006 | 0.453 | Check point kinase 2 inhibitor | 0.453 0.004 DBMET01440 0.251 0.01 DBMET01441 | DBMET01440 | |
| 0.305 | 0.004 | 0.704 | Cyclin B3 inhibitor | 0.704 0.002 DBMET01440 0.256 0.004 DBMET01441 | DBMET01440 | |
| 0.324 | 0.024 | 0.324 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.198 0.075 DBMET01440 0.237 0.048 DBMET01441 | ||
| 0.308 | 0.013 | 0.308 | Focal adhesion kinase 2 inhibitor | 0.208 0.063 DBMET01441 | ||
| 0.298 | 0.004 | 0.434 | MAP3K7 inhibitor | 0.434 0.003 DBMET01440 0.251 0.005 DBMET01441 | DBMET01440 | |
| 0.301 | 0.01 | 0.301 | TRKB antagonist | 0.153 0.045 DBMET01440 0.198 0.026 DBMET01441 | ||
| 0.301 | 0.011 | 0.301 | Hexokinase inhibitor | 0.185 0.045 DBMET01440 0.291 0.012 DBMET01441 | ||
| 0.294 | 0.013 | 0.294 | Polo-like kinase-3 inhibitor | 0.193 0.049 DBMET01440 0.237 0.029 DBMET01441 | ||
| 0.281 | 0.002 | 0.281 | Cyclin D1 inhibitor | 0.12 0.005 DBMET01440 0.193 0.003 DBMET01441 | ||
| 0.393 | 0.117 | 0.519 | Apoptosis agonist | 0.475 0.082 DBMET01440 0.519 0.069 DBMET01441 | DBMET01441 | |
| 0.278 | 0.006 | 0.278 | Aurora-C kinase inhibitor | 0.245 0.01 DBMET01440 0.244 0.01 DBMET01441 | ||
| 0.286 | 0.014 | 0.286 | Cyclin-dependent kinase 7 inhibitor | 0.204 0.032 DBMET01440 0.233 0.024 DBMET01441 | ||
| 0.317 | 0.051 | 0.381 | DNA damaging | 0.381 0.033 DBMET01440 0.321 0.05 DBMET01441 | DBMET01440 | |
| 0.266 | 0.013 | 0.266 | Epidermal growth factor receptor kinase inhibitor | 0.224 0.02 DBMET01440 0.188 0.03 DBMET01441 | ||
| 0.267 | 0.015 | 0.462 | Cyclin-dependent kinase 2 inhibitor | 0.462 0.005 DBMET01440 0.205 0.023 DBMET01441 | DBMET01440 | |
| 0.264 | 0.018 | 0.264 | Activin receptor-like kinase 2 inhibitor | 0.166 0.056 DBMET01441 | ||
| 0.25 | 0.004 | 0.25 | MAP-kinase-activated kinase inhibitor | 0.227 0.005 DBMET01440 0.222 0.005 DBMET01441 | ||
| 0.278 | 0.034 | 0.307 | Peptidyltransferase inhibitor | 0.267 0.04 DBMET01440 0.307 0.022 DBMET01441 | DBMET01441 | |
| 0.248 | 0.007 | 0.248 | Insulin receptor antagonist | 0.171 0.021 DBMET01441 | ||
| 0.242 | 0.011 | 0.242 | Epidermal growth factor antagonist | 0.219 0.013 DBMET01440 0.139 0.026 DBMET01441 | ||
| 0.237 | 0.006 | 0.322 | MAP kinase 11 inhibitor | 0.322 0.005 DBMET01440 0.187 0.011 DBMET01441 | DBMET01440 | |
| 0.236 | 0.011 | 0.236 | MAP kinase 3 inhibitor | 0.204 0.022 DBMET01440 0.199 0.024 DBMET01441 | ||
| 0.234 | 0.01 | 0.234 | Polo-like kinase-4 inhibitor | 0.093 0.085 DBMET01440 0.198 0.016 DBMET01441 | ||
| 0.242 | 0.018 | 0.242 | Cyclin-dependent kinase 8 inhibitor | 0.123 0.113 DBMET01440 0.206 0.032 DBMET01441 | ||
| 0.229 | 0.005 | 0.229 | CDC-like kinase 3 inhibitor | 0.198 0.007 DBMET01440 0.189 0.009 DBMET01441 | ||
| 0.225 | 0.004 | 0.225 | MAP-kinase-activated kinase 2 inhibitor | 0.211 0.005 DBMET01440 0.2 0.005 DBMET01441 | ||
| 0.231 | 0.012 | 0.253 | MAP kinase kinase kinase inhibitor | 0.179 0.024 DBMET01440 0.253 0.01 DBMET01441 | DBMET01441 | |
| 0.232 | 0.016 | 0.347 | Antineoplastic antibiotic | 0.3 0.009 DBMET01440 0.347 0.007 DBMET01441 | DBMET01441 | |
| 0.218 | 0.004 | 0.218 | CDK3/cyclin E inhibitor | 0.201 0.006 DBMET01440 0.2 0.006 DBMET01441 | ||
| 0.244 | 0.032 | 0.326 | Diuretic | 0.326 0.019 DBMET01441 | DBMET01441 | |
| 0.246 | 0.043 | 0.246 | P-glycoprotein inhibitor | 0.18 0.08 DBMET01440 0.198 0.065 DBMET01441 | ||
| 0.229 | 0.032 | 0.299 | Vascular endothelial growth factor 3 antagonist | 0.299 0.019 DBMET01440 0.15 0.066 DBMET01441 | DBMET01440 | |
| 0.189 | 0.008 | 0.189 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.162 0.012 DBMET01440 0.153 0.014 DBMET01441 | ||
| 0.211 | 0.03 | 0.211 | CDC-like kinase 1 inhibitor | 0.155 0.067 DBMET01440 0.16 0.063 DBMET01441 | ||
| 0.213 | 0.034 | 0.284 | Cyclin-dependent kinase inhibitor | 0.284 0.022 DBMET01440 0.17 0.047 DBMET01441 | DBMET01440 | |
| 0.177 | 0.004 | 0.177 | Polo-like kinase-2 inhibitor | 0.135 0.005 DBMET01440 0.147 0.005 DBMET01441 | ||
| 0.207 | 0.039 | 0.207 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.148 0.075 DBMET01440 0.146 0.077 DBMET01441 | ||
| 0.165 | 0.002 | 0.172 | MAP kinase kinase 7 inhibitor | 0.132 0.004 DBMET01440 0.172 0.002 DBMET01441 | DBMET01441 | |
| 0.185 | 0.022 | 0.185 | Protein kinase (CK2) inhibitor | 0.156 0.03 DBMET01441 | ||
| 0.164 | 0.004 | 0.181 | Cyclin-dependent kinase 6 inhibitor | 0.181 0.004 DBMET01440 0.138 0.005 DBMET01441 | DBMET01440 | |
| 0.186 | 0.027 | 0.186 | Protein kinase (CK2) alpha inhibitor | 0.143 0.046 DBMET01441 | ||
| 0.156 | 0.003 | 0.156 | MAP kinase 7 inhibitor | 0.132 0.004 DBMET01440 0.128 0.004 DBMET01441 | ||
| 0.16 | 0.011 | 0.236 | Cyclin-dependent kinase 4 inhibitor | 0.236 0.005 DBMET01440 0.136 0.014 DBMET01441 | DBMET01440 | |
| 0.16 | 0.016 | 0.272 | Rho-associated kinase II inhibitor | 0.202 0.011 DBMET01440 0.272 0.007 DBMET01441 | DBMET01441 | |
| 0.171 | 0.03 | 0.171 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.143 | 0.004 | 0.311 | Cyclin E2 inhibitor | 0.311 0.003 DBMET01440 0.086 0.005 DBMET01441 | DBMET01440 | |
| 0.159 | 0.025 | 0.159 | Pim-1 kinase inhibitor | 0.09 0.068 DBMET01440 0.134 0.034 DBMET01441 | ||
| 0.135 | 0.002 | 0.277 | Protein kinase C beta I inhibitor | 0.277 0.001 DBMET01440 0.094 0.002 DBMET01441 | DBMET01440 | |
| 0.135 | 0.002 | 0.226 | Protein kinase C beta II inhibitor | 0.11 0.003 DBMET01440 0.226 0.002 DBMET01441 | DBMET01441 | |
| 0.323 | 0.194 | 0.323 | Antiinflammatory | 0.294 0.221 DBMET01441 | ||
| 0.148 | 0.022 | 0.148 | TIE-2 antagonist | 0.106 0.036 DBMET01441 | ||
| 0.195 | 0.069 | 0.195 | CDC-like kinase 2 inhibitor | 0.12 0.119 DBMET01441 | ||
| 0.147 | 0.023 | 0.147 | TIE antagonist | 0.106 0.037 DBMET01441 | ||
| 0.145 | 0.022 | 0.145 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.132 | 0.014 | 0.221 | Cyclin E inhibitor | 0.221 0.005 DBMET01440 0.116 0.019 DBMET01441 | DBMET01440 | |
| 0.147 | 0.031 | 0.219 | MAP kinase 8 inhibitor | 0.219 0.014 DBMET01440 0.116 0.046 DBMET01441 | DBMET01440 | |
| 0.146 | 0.032 | 0.146 | EphA2 antagonist | |||
| 0.125 | 0.013 | 0.23 | Cyclin E1 inhibitor | 0.23 0.005 DBMET01440 0.109 0.017 DBMET01441 | DBMET01440 | |
| 0.145 | 0.037 | 0.145 | Sphingosine 1-phosphate receptor 4 antagonist | 0.117 0.079 DBMET01441 | ||
| 0.132 | 0.025 | 0.132 | Pim-3 kinase inhibitor | 0.101 0.045 DBMET01441 | ||
| 0.202 | 0.099 | 0.202 | Platelet antagonist | 0.187 0.111 DBMET01441 | ||
| 0.11 | 0.009 | 0.371 | Cyclin B1 inhibitor | 0.371 0.003 DBMET01440 0.091 0.015 DBMET01441 | DBMET01440 | |
| 0.106 | 0.008 | 0.365 | Cyclin B2 inhibitor | 0.365 0.003 DBMET01440 0.086 0.012 DBMET01441 | DBMET01440 | |
| 0.103 | 0.007 | 0.103 | Cyclin H inhibitor | 0.089 0.013 DBMET01440 0.091 0.012 DBMET01441 | ||
| 0.145 | 0.052 | 0.177 | DNA polymerase I inhibitor | 0.142 0.054 DBMET01440 0.177 0.036 DBMET01441 | DBMET01441 | |
| 0.164 | 0.074 | 0.164 | Src kinase inhibitor | 0.147 0.085 DBMET01440 | ||
| 0.092 | 0.003 | 0.092 | MAP3K5 inhibitor | 0.048 0.014 DBMET01440 0.092 0.003 DBMET01441 | ||
| 0.099 | 0.01 | 0.322 | Cyclin B inhibitor | 0.322 0.004 DBMET01440 0.078 0.016 DBMET01441 | DBMET01440 | |
| 0.138 | 0.049 | 0.152 | Glycogen synthase kinase-3 beta inhibitor | 0.152 0.042 DBMET01440 0.096 0.083 DBMET01441 | DBMET01440 | |
| 0.102 | 0.014 | 0.139 | CDK4/cyclin D1 inhibitor | 0.139 0.008 DBMET01440 0.091 0.018 DBMET01441 | DBMET01440 | |
| 0.205 | 0.117 | 0.215 | Immunostimulant | 0.215 0.111 DBMET01441 | DBMET01441 | |
| 0.144 | 0.059 | 0.167 | c-Src kinase inhibitor | 0.167 0.047 DBMET01440 | DBMET01440 | |
| 0.166 | 0.088 | 0.166 | CDC-like kinase 4 inhibitor | |||
| 0.137 | 0.061 | 0.137 | Protein kinase (CK1) delta inhibitor | |||
| 0.093 | 0.019 | 0.093 | ZAP-70 protein tyrosine kinase inhibitor | 0.081 0.033 DBMET01440 0.082 0.032 DBMET01441 | ||
| 0.184 | 0.118 | 0.184 | Vasodilator | 0.181 0.121 DBMET01440 | ||
| 0.106 | 0.04 | 0.106 | Aminoacyl-tRNA synthetase inhibitor | 0.089 0.059 DBMET01440 0.098 0.048 DBMET01441 | ||
| 0.067 | 0.004 | 0.067 | LIM domain kinase 2 inhibitor | 0.044 0.008 DBMET01440 0.043 0.008 DBMET01441 | ||
| 0.122 | 0.06 | 0.13 | Glycogen synthase kinase-3 inhibitor | 0.13 0.055 DBMET01440 | DBMET01440 | |
| 0.119 | 0.058 | 0.119 | DNA intercalator | 0.103 0.071 DBMET01440 0.118 0.059 DBMET01441 | ||
| 0.088 | 0.03 | 0.094 | CDK1/cyclin B inhibitor | 0.094 0.027 DBMET01440 0.065 0.042 DBMET01441 | DBMET01440 | |
| 0.093 | 0.036 | 0.093 | Janus tyrosine kinase 3 inhibitor | 0.078 0.046 DBMET01441 | ||
| 0.109 | 0.061 | 0.109 | Vascular endothelial growth factor 1 antagonist | |||
| 0.082 | 0.037 | 0.082 | CDK1/cyclin B1 inhibitor | 0.065 0.053 DBMET01441 | ||
| 0.145 | 0.103 | 0.145 | LIM domain kinase 1 inhibitor | |||
| 0.081 | 0.042 | 0.081 | Protein kinase B beta inhibitor | 0.075 0.048 DBMET01440 0.072 0.054 DBMET01441 | ||
| 0.068 | 0.029 | 0.088 | CDK4/cyclin D inhibitor | 0.088 0.018 DBMET01440 0.061 0.036 DBMET01441 | DBMET01440 | |
| 0.124 | 0.088 | 0.124 | Growth factor antagonist | |||
| 0.076 | 0.04 | 0.076 | I kappa B kinase 1 inhibitor | |||
| 0.118 | 0.086 | 0.118 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.154 | 0.127 | 0.154 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.079 | 0.053 | 0.079 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.072 | 0.05 | 0.072 | Telomerase inhibitor | |||
| 0.056 | 0.034 | 0.062 | Protein 50S ribosomal subunit inhibitor | 0.062 0.029 DBMET01440 0.053 0.037 DBMET01441 | DBMET01440 | |
| 0.111 | 0.092 | 0.13 | Lck kinase inhibitor | 0.13 0.078 DBMET01440 | DBMET01440 | |
| 0.046 | 0.029 | 0.046 | Poly(ADP-ribose) polymerase inhibitor | 0.046 0.029 DBMET01441 | ||
| 0.14 | 0.124 | 0.14 | Clk dual-specificity kinase inhibitor | |||
| 0.041 | 0.026 | 0.041 | Cyclin D3 inhibitor | |||
| 0.066 | 0.053 | 0.066 | CDK2/cyclin E2 inhibitor | |||
| 0.066 | 0.053 | 0.066 | Syk tyrosine kinase inhibitor | |||
| 0.084 | 0.074 | 0.084 | Polo-like kinase-1 inhibitor | |||
| 0.037 | 0.027 | 0.037 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.037 0.027 DBMET01441 | ||
| 0.019 | 0.01 | 0.025 | Sodium/hydrogen exchanger inhibitor | 0.025 0.005 DBMET01440 | DBMET01440 | |
| 0.193 | 0.187 | 0.237 | Antithrombotic | 0.237 0.136 DBMET01441 | DBMET01441 | |
| 0.065 | 0.06 | 0.119 | Rho-associated kinase inhibitor | 0.078 0.048 DBMET01440 0.119 0.027 DBMET01441 | DBMET01441 | |
| 0.038 | 0.033 | 0.041 | Phenylethanolamine N methyltransferase inhibitor | 0.041 0.028 DBMET01441 | DBMET01441 | |
| 0.077 | 0.072 | 0.089 | CDK/cyclin complex inhibitor | 0.089 0.06 DBMET01440 | DBMET01440 | |
| 0.1 | 0.097 | 0.1 | RET inhibitor | |||
| 0.113 | 0.114 | 0.117 | Tyrosine kinase inhibitor | 0.117 0.111 DBMET01441 | DBMET01441 | |
| 0.089 | 0.097 | 0.1 | Topoisomerase II inhibitor | 0.1 0.086 DBMET01441 | DBMET01441 | |
| 0.067 | 0.099 | 0.083 | CDK2/cyclin A inhibitor | 0.083 0.076 DBMET01440 | DBMET01440 | |
| 0.148 | 0.204 | 0.167 | RNA-directed DNA polymerase inhibitor | 0.167 0.159 DBMET01441 | DBMET01441 | |
| 0.141 | 0.222 | 0.201 | DNA synthesis inhibitor | 0.201 0.122 DBMET01440 0.196 0.129 DBMET01441 | DBMET01440 | |
| 0.008 | 0.214 | 0.044 | 1,3-Beta-glucan synthase inhibitor | 0.044 0.003 DBMET01440 | DBMET01440 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |